Ventripoint Diagnostics Stock Analysis

VentriPoint Pink Sheet Analysis Notes

The company recorded a loss per share of 0.02. VentriPoint Diagnostics had not issued any dividends in recent years. The entity had 1:10 split on the 7th of December 2015. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company was incorporated in 2004 and is based in Toronto, Canada. Ventripoint Diagnostics is traded on OTC Exchange in the United States.The quote for VentriPoint Diagnostics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call BASc ICDD at 416-848-4156 or visit https://www.ventripoint.com.

VentriPoint Diagnostics Investment Alerts

VentriPoint Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 32.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VentriPoint Diagnostics's market, we take the total number of its shares issued and multiply it by VentriPoint Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 2nd of February, VentriPoint Diagnostics has the Variance of 53.51, coefficient of variation of (1,788), and Risk Adjusted Performance of (0.04). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of VentriPoint Diagnostics, as well as the relationship between them. Please validate VentriPoint Diagnostics market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if VentriPoint Diagnostics is priced more or less accurately, providing market reflects its prevalent price of 0.07 per share. As VentriPoint Diagnostics appears to be a penny stock we also recommend to double-check its jensen alpha numbers.

VentriPoint Diagnostics Price Movement Analysis

VentriPoint Diagnostics Predictive Daily Indicators

VentriPoint Diagnostics Forecast Models

VentriPoint Diagnostics' time-series forecasting models are one of many VentriPoint Diagnostics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VentriPoint Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how VentriPoint Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VentriPoint shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as VentriPoint Diagnostics. By using and applying VentriPoint Pink Sheet analysis, traders can create a robust methodology for identifying VentriPoint entry and exit points for their positions.

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.